Stockscreener 앱 받기
7.52
1.48%
0.11
Xeris Biopharma Holdings Inc 주식(XERS)의 최신 뉴스
Does Xeris Biopharma (XERS) Boosted 2025 Revenue Guidance Strengthen Its Commercial Momentum Narrative? - simplywall.st
How Investors Are Reacting To Xeris Biopharma (XERS) Raising 2025 Revenue Outlook And Recorlev Momentum - Sahm
Technical Analysis: What are Xeris Biopharma Holdings Incs technical support levels2025 Price Momentum & Smart Investment Allocation Insights - baoquankhu1.vn
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is It Too Late To Consider Xeris Biopharma Holdings (XERS) After Its 133% One-Year Surge? - Yahoo Finance
Assessing Xeris Biopharma Holdings (XERS) Valuation After Strong Recent Shareholder Returns - Yahoo Finance
Is Xeris Biopharma Holdings (XERS) Price Rally Still Justified After Recent Company Updates - Sahm
Why Xeris Biopharma Holdings (XERS) Is Up 7.9% After Raising 2025 Revenue Outlook and Adding Patents - Yahoo Finance
XERS: HC Wainwright & Co. Reiterates Buy Rating with $10.00 Pric - GuruFocus
Insider Selling: Xeris Biopharma (NASDAQ:XERS) Insider Sells 15,000 Shares of Stock - MarketBeat
Xeris Biopharma (NASDAQ:XERS) Earns Buy Rating from HC Wainwright - MarketBeat
Published on: 2026-01-13 01:49:04 - ulpravda.ru
Will Xeris Biopharma Holdings Inc. stock outperform tech sector in 20252025 EndofYear Setup & Weekly High Potential Stock Alerts - Улправда
Xeris Biopharma (XERS) Exceeds 2025 Revenue Expectations - GuruFocus
Breakout Move: Is Xeris Biopharma Holdings Inc. stock a smart buy before Fed meetingJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
How Xeris Biopharma Holdings Inc. stock benefits from strong dollarJuly 2025 Update & AI Powered Buy and Sell Recommendations - Улправда
Is Xeris Biopharma Holdings Inc. stock positioned well for digital economyBreakout Watch & Smart Allocation Stock Reports - Улправда
Xeris Biopharma expects full-year 2025 revenue above estimates - MSN
Xeris Biopharma (NASDAQ:XERS) Shares Gap UpHere's Why - MarketBeat
Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue - BioSpace
Xeris Biopharma Holdings, Inc. Updates Earnings Guidance for the Full-Year 2025 - marketscreener.com
A biotech treating 700 patients is on track for a record revenue year - Stock Titan
Xeris Biopharma director Shannon sells $176k in shares By Investing.com - Investing.com Nigeria
Xeris Biopharma director Shannon sells $176k in shares - Investing.com
Xeris Biopharma (NASDAQ:XERS) Insider Sells $176,341.56 in Stock - MarketBeat
Beth Hecht Sells 16,667 Shares of Xeris Biopharma (NASDAQ:XERS) Stock - MarketBeat
Xeris Biopharma Holdings, Inc. $XERS Shares Sold by Diversified Trust Co - MarketBeat
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Xeris Biopharma (NASDAQ:XERS) Trading Down 6.8%Time to Sell? - MarketBeat
Calamos Advisors LLC Makes New Investment in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday - Finviz
Is Xeris Biopharma on the Verge of a Breakthrough? - StocksToTrade
Xeris Biopharma Holdings Inc. (XERS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
XERS FinancialsIncome Statement - Quiver Quantitative
Investors Buy Large Volume of Call Options on Xeris Biopharma (NASDAQ:XERS) - MarketBeat
Jefferies reiterates Buy rating on Xeris Pharmaceuticals stock amid competitor setback By Investing.com - Investing.com Nigeria
Jefferies reiterates Buy rating on Xeris Pharmaceuticals stock amid competitor setback - Investing.com
Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue? - MSN
Xeris Biopharma Holdings, Inc. $XERS Shares Acquired by Voya Investment Management LLC - MarketBeat
Oppenheimer Maintains Xeris Biopharma Holdings (XERS) Outperform Recommendation - MSN
Have Xeris Biopharma Holdings Insiders Been Selling Stock? - Sahm
Will Xeris Biopharma Holdings Inc. stock pay special dividendsStop Loss & Target Return Focused Stock Picks - Улправда
Will Xeris Biopharma Holdings Inc. stock benefit from sector rotationJuly 2025 Technicals & High Accuracy Buy Signal Tips - Улправда
Squarepoint Ops LLC Purchases 268,572 Shares of Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Xeris Biopharma (XERS): Assessing Valuation as Investors Back Its Shift to Profitable Specialty Pharma - Sahm
EBIT per share of Xeris Biopharma Holdings, Inc. – LSE:0A8E - TradingView — Track All Markets
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Director John Johnson Sells 135,400 Shares of Xeris Biopharma Ho - GuruFocus
4.73%
0.92%
자본화:
|
볼륨(24시간):